1. Inflammation and fibrogenesis in steatohepatitis

   • Hideki Fujii
   • Norifumi Kawada

   Review 07 February 2012 Pages: 215 - 225

   

2. Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded

   • Tze S. Khor
   • Hiroshi Fujita
   • Gregory Y. Lauwers

   Review 10 February 2012 Pages: 226 - 248

   

3. Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis

   • Hiroto Miwa
   • Michio Hongo
   • The J-FAST Group

   Original Article—Alimentary Tract 01 November 2011 Pages: 249 - 255

   

4. The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons

   • Matthias A. Engel
   • Mohammad Khalil
   • Peter W. Reeh

   Original Article—Alimentary Tract 12 November 2011 Pages: 256 - 265

   

5. Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer

   • Flavien Devun
   • Guilhem Bousquet
   • Marie Dutreix

   Original Article-Alimentary Tract 09 November 2011 Pages: 266 - 275

   

6. A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan

   • Toshio Fujioka
   • Nobuo Aoyama
   • Koji Yakabi

   Original Article—Alimentary Tract 09 November 2011 Pages: 276 - 283

7. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan

   • Kazunari Tominaga
   • Ryuichi Iwakiri
   • and the GERD 4 Study Group

   Original Article—Alimentary Tract 15 November 2011 Pages: 284 - 292

   

8. Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males

   • Masahiro Sogabe
   • Toshiya Okahisa
   • Akira Yamanoi

   Original Article—Liver, Pancreas, and Biliary Tract 09 November 2011 Pages: 293 - 299

   

9. Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients

   • Takuya Iwamoto
   • Shuji Terai
   • Isao Sakaida

   Original Article—Liver, Pancreas, and Biliary Tract 09 November 2011 Pages: 300 - 312

   

10. The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study

    • Yoshiyuki Narahara
    • Hidenori Kanazawa
    • Kiwamu Okita

    Original Article—Liver, Pancreas, and Biliary Tract 25 October 2011 Pages: 313 - 320

    

11. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine

    • Takeo Shimasaki
    • Yasuhito Ishigaki
    • Yoshiharu Motoo

    Original Article—Liver, Pancreas, and Biliary Tract 01 November 2011 Pages: 321 - 333

    

12. Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin

    • Tsugiko Oze
    • Naoki Hiramatsu
    • Tetsuo Takehara

    Original Article—Liver, Pancreas, and Biliary Tract 23 November 2011 Pages: 334 - 342

    

13. Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma

    • Kenya Yamanaka
    • Etsuro Hatano
    • Shinji Uemoto

    Rapid Communication 21 December 2011 Pages: 343 - 346

14. Shall we use endoscopic submucosal dissection for every gastric neoplasia?

    • László Czakó
    • Viktória Terzin
    • Tibor Szalóki

    Letter to the Editor 05 January 2012 Pages: 347 - 348

15. Reply to the letter by L. Czakó et al. regarding “Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group”

    • Motohiko Kato
    • Tsutomu Nishida
    • Tetsuo Takehara

    Letter to the Editor 11 January 2012 Pages: 349 - 349